The latest medical device regulatory and reimbursement news from Elsevier Business Intelligence's "The Gray Sheet."
You may also be interested in...
The $13 billion total joint market is facing a number of challenges coming off the recent recession. Although the demographics related to joint replacement remain strong, manufacturers continue to be plagued by downward pressure on implant prices, a slowdown in procedure volumes, and an ongoing shift in hospital purchasing. Many believe that J&J's recent acquisition of Synthes will spark a wave of consolidation in the industry.
Artificial intelligence model’s comments signal the likely start of computer-generated comments to the US FDA’s public notices.